Mr Filippo Trombara
University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/880x255/9cd18bf278/acvc-acronym-text-rgb.png)
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
Prognostic impact of percutaneous coronary intervention in chronic dialysis patients with acute myocardial infarction
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Prognosis after revascularisation in stable coronary artery disease
In-hospital and 1-year mortality associated with percutaneous coronary intervention use in patients with acute myocardial infarction older than 90 years
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Prognosis after revascularisation in stable coronary artery disease
Impact of chronic GLP-1 receptor agonist and SGLT-2 inhibitor therapy on in-hospital outcomes of patients with diabetes mellitus hospitalized with acute myocardial infarction.
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: What’s new on lipids and diabetes in acute coronary syndrome
ESC 365 is supported by
